Suchergebnisse - "Coulson, Rhiannon"

PubPharm (2)

1

CDK4/6 inhibition reprograms the breast cancer enhancer landscape by stimulating AP-1 transcriptional activity

enthalten in: Nature cancer | 2021

von Watt, A. | Cejas, P. | DeCristo, M. | +30

CommentIn: Nat Cancer. 2021 Jan;2(1):16-17. - PMID 35121894

2

MDM2 inhibition in combination with endocrine therapy and CDK4/6 inhibition for the treatment of ER-positive breast cancer

enthalten in: Breast cancer research : BCR | 2020

von Portman, N. | Milioli, H. | Alexandrou, S. | +13

1
[1]